CD40 stimulation sensitizes CLL cells to rituximab-induced cell death

被引:25
作者
Jak, M. [1 ,2 ]
van Bochove, G. G. W. [1 ]
van Lier, R. A. W. [2 ]
Eldering, E. [2 ]
van Oers, M. H. J. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands
关键词
chronic lymphocytic leukemia; anti-CD20; cell death; CD40; stimulation; CHRONIC LYMPHOCYTIC-LEUKEMIA; B-CELLS; MONOCLONAL-ANTIBODY; DOWN-REGULATION; HLA-DR; CD20; APOPTOSIS; LYMPHOMA; EXPRESSION; KINASE;
D O I
10.1038/leu.2011.39
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In vitro CD40-stimulated chronic lymphocytic leukemia (CLL) cells are resistant to cytotoxic drugs. In sharp contrast, we here show that CD40 stimulation sensitizes CLL cells to rituximab-mediated cell death. This increased sensitivity is specific for anti-CD20 treatment. Rituximab-mediated death in CD40-stimulated CLL cells shows rapid kinetics (within hours), and is caspase and p53 independent, but depends on extracellular Ca2+ and reactive oxygen species (ROS) production. By increasing basal ROS production, CD40 stimulation sensitizes CLL cells to rituximab-mediated death. Our findings provide a rationale for combination treatment of CLL with cytotoxic drugs and anti-CD20 monoclonal antibodies. Leukemia (2011) 25, 968-978; doi:10.1038/leu.2011.39; published online 15 March 2011
引用
收藏
页码:968 / 978
页数:11
相关论文
共 60 条
[1]   REDUCED EXPRESSION OF CD20 ANTIGEN AS A CHARACTERISTIC MARKER FOR CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
ALMASRI, NM ;
DUQUE, RE ;
ITURRASPE, J ;
EVERETT, E ;
BRAYLAN, RC .
AMERICAN JOURNAL OF HEMATOLOGY, 1992, 40 (04) :259-263
[2]   A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival [J].
Alvi, AJ ;
Austen, B ;
Weston, VJ ;
Fegan, C ;
MacCallum, D ;
Gianella-Borradori, A ;
Lane, DP ;
Hubank, M ;
Powell, JE ;
Wei, WB ;
Taylor, AMR ;
Moss, PAH ;
Stankovic, T .
BLOOD, 2005, 105 (11) :4484-4491
[3]   Down-regulation of CD20 on B cells upon CD40 activation [J].
Anolik, J ;
Looney, RJ ;
Bottaro, A ;
Sanz, I ;
Young, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (09) :2398-2409
[4]   Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: Relationship to in vivo rituximab resistance [J].
Bannerji, R ;
Kitada, S ;
Flinn, IW ;
Pearson, M ;
Young, D ;
Reed, JC ;
Byrd, JC .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1466-1471
[5]   Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation [J].
Bragado, Paloma ;
Armesilla, Alejandro ;
Silva, Augusto ;
Porras, Almudena .
APOPTOSIS, 2007, 12 (09) :1733-1742
[6]   Calcium, ATP, and ROS: a mitochondrial love-hate triangle [J].
Brookes, PS ;
Yoon, YS ;
Robotham, JL ;
Anders, MW ;
Sheu, SS .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (04) :C817-C833
[7]   TRANSFECTION OF THE CD20 CELL-SURFACE MOLECULE INTO ECTOPIC CELL-TYPES GENERATES A CA2+ CONDUCTANCE FOUND CONSTITUTIVELY IN B-LYMPHOCYTES [J].
BUBIEN, JK ;
ZHOU, LJ ;
BELL, PD ;
FRIZZELL, RA ;
TEDDER, TF .
JOURNAL OF CELL BIOLOGY, 1993, 121 (05) :1121-1132
[8]   The microenvironment in mature B-cell malignancies: a target for new treatment strategies [J].
Burger, Jan A. ;
Ghia, Paolo ;
Rosenwald, Andreas ;
Caligaris-Cappio, Federico .
BLOOD, 2009, 114 (16) :3367-3375
[9]   Role of the microenvironment in chronic lymphocytic leukaemia [J].
Caligaris-Cappio, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (03) :380-388
[10]   Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells [J].
Chen, Y. ;
McMillan-Ward, E. ;
Kong, J. ;
Israels, S. J. ;
Gibson, S. B. .
CELL DEATH AND DIFFERENTIATION, 2008, 15 (01) :171-182